Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SMWB
SMWB logo

SMWB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Similarweb Ltd (SMWB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
5.130
1 Day change
2.81%
52 Week Range
10.750
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Similarweb Ltd (SMWB) is not a strong buy for a beginner, long-term investor at this time. While the company has shown positive developments such as surpassing $300M ARR and securing significant enterprise contracts, the mixed analyst ratings, lack of recent trading signals, and neutral insider and hedge fund activity suggest limited immediate upside. Additionally, the stock's price is near resistance levels, and there are no clear catalysts for significant growth in the short term.

Technical Analysis

The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 68.745, and moving averages are converging, showing no clear trend. The stock is trading near its resistance level (R1: 5.199), suggesting limited upside potential in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The options data indicates a strong bullish sentiment, with a very low put-call ratio, but this may not align with the broader market sentiment or fundamentals.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
7

Positive Catalysts

  • The company has surpassed $300M in ARR and closed two significant multi-year enterprise contracts worth $47M. Revenue projections for 2026 are between $307M and $315M, which reflects growth.

Neutral/Negative Catalysts

  • Analyst ratings are mixed, with one downgrade and a reduced price target from Citi citing a lack of catalysts for the next 12 months. Insider and hedge fund activity are neutral, and there is no recent Congress trading data. The stock has limited momentum and is near resistance levels.

Financial Performance

No detailed financial data is available for the latest quarter. However, the company has shown growth in ARR and secured large contracts, which are positive indicators.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Oppenheimer raised the price target to $7 and maintains an Outperform rating, citing confidence in FY26 outlook. Barclays lowered the price target to $5, citing macroeconomic concerns and a lack of short-term catalysts. Citi downgraded the stock to Neutral with a price target of $3, reflecting a cautious stance on the software sector.

Wall Street analysts forecast SMWB stock price to rise
5 Analyst Rating
Wall Street analysts forecast SMWB stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 4.990
sliders
Low
10
Averages
12.5
High
14
Current: 4.990
sliders
Low
10
Averages
12.5
High
14
Oppenheimer
Oppenheimer
Outperform
maintain
$4 -> $7
AI Analysis
2026-06-18
New
Reason
Oppenheimer
Oppenheimer
Price Target
$4 -> $7
AI Analysis
2026-06-18
New
maintain
Outperform
Reason
Oppenheimer raised the firm's price target on Similarweb to $7 from $4 and keeps an Outperform rating on the shares. Earlier this week, Similarweb announced surpassing $300M ARR after closing two 7-figure multi-year enterprise contracts. While guidance was not updated, management clarified that the large deals reinforced confidence in the FY26 outlook, the firm says. Oppenheimer adjusted Q2/FY26 estimates upward to account for the transactions.
Barclays
Raimo Lenschow
Overweight
maintain
$7 -> $5
2026-04-20
Reason
Barclays
Raimo Lenschow
Price Target
$7 -> $5
2026-04-20
maintain
Overweight
Reason
Barclays analyst Raimo Lenschow lowered the firm's price target on Similarweb to $5 from $7 and keeps an Overweight rating on the shares. The firm adjusted targets in the software group as part of a Q1 earnings preview. "We are not sure Q1 will turn the negative software sentiment around," the analyst tells investors in a research note. Barclays says Q1 is the seasonally smallest quarter and that the macro backdrop "was not a tailwind." Its main concern is that fundamental improvements for software will have to wait until the second half of 2026.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SMWB
Unlock Now

People Also Watch